Category Archives: Canopy Growth

‘It’s a game changer’: Ontario company prepares Canada’s first outdoor cannabis crop

Ontario-based 48North is laying the groundwork for what would be Canada’s first large-scale outdoor marijuana crop under the Cannabis Act this spring, pending required permits from Health Canada. “With Health Canada’s permission and approval, we’ll be doing a very large outdoor grow for 2019,” co-CEO Jeannette VanderMarel told Marijuana Business Daily. “I’m hoping it’s in […]

Aphria seeks EU GMP certification prior to closing deal for German distributor

Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]

Canadian marijuana producer Aphria aims to list on the New York Stock Exchange

Aphria, one of Canada’s largest cannabis producers, has filed documents with U.S. securities regulators signaling its intent to list its shares on the New York Stock Exchange. If approved, the Ontario-based company will join a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the globe’s largest pool of institutional […]

Marijuana exchange-traded fund takes in $22 million in August

Investors are flocking to a U.S.-listed exchange-traded fund (ETF) that tracks nearly 40 Canadian and American cannabis firms. The $436 million ETFMG Alternative Harvest ETF – which trades on the NYSE Arca under the ticker symbol MJ – has taken in around $22 million in August, putting it in a position to post its largest monthly inflow […]

Bruce Linton discusses deploying CA$5 billion, Canopy’s commitment to international growth

Canopy Growth CEO Bruce Linton, right, engages in a Q&A session with Matt Lamers, the International Editor for Marijuana Business Daily. (Photo by Jules Clifford / Soliman Productions) (This story has been updated from an earlier version.) Canopy Growth, a Canadian medical marijuana giant, is taking a massive 5 billion Canadian dollar ($3.8 billion) investment […]

How high is too high? Valuations continue to climb for Canadian cannabis businesses

As more cannabis companies go public and private businesses raise capital at an unprecedented clip, valuations have become a hot topic among industry observers, insiders and investors. That’s especially true in Canada, where a growing number of cannabis firms have fetched multibillion-dollar valuations in the public markets as they’ve hustled to become a top player […]